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Abstract
In this study, we successfully established retrovirus-based reporter viruses pseudotyped with the precursor membrane and envelope (PrM/E)
proteins of each of the four serotypes of dengue viruses, which caused the most important arboviral diseases in this century. Co-sedimentation of
the dengue E protein and HIV-1 core proteins by sucrose gradient analysis of the pseudotype reporter virus of dengue virus type 2, D2(HIVluc),
and detection of HIV-1 core proteins by immunoprecipitation with anti-E monoclonal antibody suggested that dengue viral proteins were
incorporated into the pseudotype viral particles. The infectivity in target cells, as assessed by the luciferase activity, can be inhibited by the
lysosomotropic agents, suggesting a pH-dependent mechanism of entry. Amino acid substitutions of the leucine at position 107, a critical residue
at the fusion loop of E protein, with lysine resulted in severe impairment in infectivity, suggesting that entry of the pseudotype reporter virus is
mediated through the fusogenic properties of E protein. With more and more dengue viral sequences available from different outbreaks worldwide,
this sensitive and convenient tool has the potential to facilitate molecular characterization of the PrM/E proteins of dengue field isolates.
© 2007 Elsevier Inc. All rights reserved.Keywords: Dengue virus; Pseudotype reporter virusIntroduction
Among the 70 or so arthropod-borne flaviviurses, epidemics
of the four serotypes of dengue virus (DENV1, DENV2,
DENV3, and DENV4) continue to be a major public health
problem in the tropical and subtropical areas (Gubler, 2002;
Guzman and Kouri, 2002). It has been estimated that more than
2.5 billion people in over 100 countries are at risk of infection,
and approximately 100 million dengue infections occur
annually worldwide (Gubler, 2002; Guzman and Kouri,
2002). The clinical presentations of dengue virus infection
range from asymptomatic infection, to a relatively mild disease,
dengue fever, and severe and potentially life-threatening⁎ Corresponding author. Institute of Microbiology, National Taiwan Uni-
versity, No 1 Sec1 Jen-Ai Rd, Taipei 100, Taiwan. Fax: +886 2 2391 5293.
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doi:10.1016/j.virol.2007.06.026diseases, dengue hemorrhagic fever/dengue shock syndrome
(Gubler, 2002; Guzman and Kouri, 2002).
Dengue viruses are members of the genus Flavivirus in the
family Flaviviridae. It contains a positive-sense, single-stranded
RNA genome of approximately 10,600 bases in length. Flanked
by the 5′ and 3′ non-translated regions, the single open reading
frame of the genome encodes a polyprotein precursor, which is
subsequently cleaved by cellular and viral protease into three
structural proteins, the capsid (C), precursor membrane (PrM),
and envelope (E), as well as seven non-structural (NS) proteins,
NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5 (Lindenbach
and Rice, 2001). After the interaction of E protein with the
cellular receptor, dengue virus is believed to enter the cell
through receptor mediated endocytosis (Guirakhoo et al., 1993;
Lindenbach and Rice, 2001; Mukhopadhyay et al., 2005;
Randolph and Stollar, 1990). The acidic environment in the
endosome triggers a series of conformational changes of E
protein, which result in the fusion of viral and endosomal
Fig. 1. Generation of pseudotype reporter viruses, D2(HIVluc) and D2VSV
(HIVluc). (A) Schematic drawing of constructs expressing the PrM/E proteins of
DENV2. PCR product containing the entire PrM/E gene and the 3′ 42-
nucleotides of C gene (amino acid residues 101 to 114) of DENV2 was cloned
into a pCDNA3-based vector (Chang et al., 2003) to generate pCB-D2. For
pCB-D2VSV, the TM domain of the E protein of DENV2 was replaced with the
TM and CY domains of VSV-G (hatched bar). The numbers indicate amino acid
positions of the C and E proteins. (B, C) Plasmid pCB-D2 or pCB-D2VSV was
co-transfected with pNL4-3.Luc.R-E− to 293T cells (Connor et al., 1995). 60 h
later, cell lysates (B) and pellet lysates (C) derived from sucrose cushion
ultracentrifugation were subjected to Western blot analysis by using serum from
dengue patient (anti-DV) or HIV-1 patient (anti-HIV). Arrowheads indicate the
structure proteins of dengue virus and HIV-1. The size of molecular weight
markers is shown in kilodaltons.
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(Lindenbach and Rice, 2001;Modis et al., 2004;Mukhopadhyay
et al., 2005). Following translation and genome replication,
assembly occurs in the membrane structures derived from ER
and the virions are released through the secretary pathway
(Lindenbach and Rice, 2001; Mukhopadhyay et al., 2005).
The PrM/E proteins of dengue virus, present as a hetero-
dimer on the surface of the virion, are the major determinants of
cellular tropism of dengue virus (Bray et al., 1998; Chen et al.,
1995; Gualano et al., 1998; Kawano et al., 1993; Lindenbach
and Rice, 2001; Modis et al., 2004; Mukhopadhyay et al.,
2005). In addition, PrM/E proteins are the major targets of
neutralizing and enhancing antibodies, which are thought to
play important roles in the pathogenesis of dengue (Green and
Rothman, 2006; Guzman and Kouri, 2002; Halstead, 1988;
Lindenbach and Rice, 2001). With the establishment of full-
length infectious cDNA clones of dengue viruses and
generation of chimeric clones, the functions of PrM/E proteins
in the context of viral particles can be investigated (Blaney et
al., 2004; Bray and Lai, 1991; Chen et al., 1995; Gualano et
al., 1998; Kapoor et al., 1995; Kinney et al., 1997; Lai et al.,
1991; Puri et al., 2000; Sriburi et al., 2001; Whitehead et al.,
2003a,b). However, the requirement of multiple steps includ-
ing in vitro transcription, RNA transfection and infectivity
assay, which is laborious and time-consuming, has restricted
its wide use. A convenient system is needed to facilitate
molecular characterization of the PrM/E proteins of dengue
viruses.
Pseudotype reporter viruses that contain the E protein of one
virus and the core and genome with reporter gene of another
virus have been shown to be a convenient molecular tool to
study the functions of E protein, such as tropism, mechanism of
entry, sensitivity to neutralization, enhancement and entry
inhibitors (Bartosch et al., 2003; Buonocore et al., 2002; Chan
et al., 2001; Cronin et al., 2005; Deng et al., 1997; Fukushi et
al., 2005; Giroglou et al., 2004; Hanika et al., 2005; Hsu et al.,
2003; Ma et al., 1999; Matsuura et al., 2001; Moore et al.,
2004; Nie et al., 2004; Simmons et al., 2004; Wool-Lewis and
Bates, 1998). Retrovirus-based reporter viruses pseudotyped
with the E proteins of different families of RNA viruses,
including simian immunodeficiency virus, hepatitis C virus
(HCV), Ebola virus, La Crosse virus, Hantaan virus, and
SARS-CoV, have been successfully established (Bartosch et al.,
2003; Chan et al., 2001; Deng et al., 1997; Giroglou et al.,
2004; Hsu et al., 2003; Ma et al., 1999; Moore et al., 2004; Nie
et al., 2004; Simmons et al., 2004; Wool-Lewis and Bates,
1998). In this study, we developed a lentivirus-based
pseudotype reporter virus for dengue virus, which contains
the core and defective genome of human immunodeficiency
virus type 1 (HIV-1), the luciferase reporter gene, and the PrM/
E proteins of one of the four serotypes of dengue viruses. We
characterized the biochemical properties of the pseudotype
reporter viral particles and demonstrated that they enter target
cells through a pH-dependent mechanism. Moreover, mutations
introduced to a critical residue at the fusion loop of E protein
resulted in impairment in infectivity of the pseudotype reporter
virus.Results
Generation of pseudotype reporter viruses containing PrM/E
protein of DENV2
We first generated a pseudotype reporter virus, D2(HIVluc),
by co-transfection of the PrM/E-expressing construct of
DENV2, pCB-D2, and the lentivirus-based luciferase reporter
construct, pNL4-3.Luc.R-E− (Fig. 1A). Since particle forma-
tion of lentivirus and dengue virus is known to occur at different
subcellular locations, i.e. plasma membrane for lentivirus and
ER for dengue virus (Freed and Martin, 2001; Lindenbach and
Rice, 2001), we next constructed a chimeric PrM/E-expressing
plasmid, pCB-D2VSV, by replacing the TM domain of E
protein with the TM and CY domains of VSV G protein, which
contained the membrane-targeting signal (Rose and Whitt,
2001), to enhance the surface expression of PrM/E protein and
generated the pseudotype reporter virus, D2VSV(HIVluc) (Fig.
1A). Western blot analysis of the cell lysates revealed com-
patible amounts of PrM and E proteins, indicating that the
expression of PrM/E protein was intact in the constructs pCB-
D2 and pCB-D2VSV (Fig. 1B). To detect proteins present in the
pseudotype reporter viral particles, pellets derived from the
Fig. 2. Sucrose gradient analysis of pseudotype reporter viruses, D2(HIVluc)
and D2VSV(HIVluc). Pellets of D2(HIVluc) (A, B) and D2VSV(HIVluc) (E, F)
were subjected to sucrose gradient (15% to 80% (wt./vol.)) ultracentrifugation,
and pellets derived from each fraction to Western blot analysis by using serum
from dengue patient (A, E) or HIV-1 patient (B, F). Arrowheads indicate the
structure proteins of dengue virus and HIV-1. The size of molecular weight
markers is shown in kilodaltons. Fraction numbers (1 to 9, from top to bottom)
are shown above each lane. The amounts of p24 (open square) and buoyant
density (closed circle) of each fraction were determined for D2(HIVluc) (C) and
D2VSV(HIVluc) (G). Electron micrographs of D2(HIVluc) (D) and D2VSV
(HIVluc) (H) were taken after staining with uranyl acetate. Magnification:
100,000×. Bar: 100 nm.
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in Fig. 1C, the PrM and E proteins of dengue virus were
detectable by serum from dengue patient. In addition, the matrix
(p17), capsid (p24) and reverse transcriptase (p51 and p66) of
HIV-1 were detectable by serum from HIV-1 patient (Fig. 1C).
These findings suggested that the envelope glycoproteins of
dengue virus, PrM and E, and the structural proteins of HIV-1
core were present in the pseudotype reporter viruses, D2
(HIVluc) and D2VSV(HIVluc).
Incorporation of dengue viral proteins into pseudotype
reporter viruses
To further investigate whether the PrM/E proteins were
indeed incorporated into the pseudotype reporter viral particles,
the pellets derived from supernatants were subjected to sucrose
gradient analysis, and the pellet of each fraction to Western blot
analysis. Of the fractions derived from D2(HIVluc), while the E
protein of DENV2 were detected in fractions 3 to 6 and HIV-1
core proteins in fractions 4 to 6, the majority of E protein and
HIV-1 core proteins co-sedimented in fractions 4 and 5,
suggesting that they were incorporated into the pseudotype
reporter viral particles, D2(HIVluc) (Figs. 2A and B). More-
over, analysis of p24 by ELISA in each fraction revealed that
the peak of p24 was in fraction 5, corresponding to a buoyant
density of 1.14 g/ml (Fig. 2C). Similarly, analysis of fractions
derived from D2VSV(HIVluc) revealed co-sedimentation of the
majority of E protein and HIV-1 core proteins with the peak of
p24 in fraction 5, which also corresponded to a buoyant density
of 1.14 g/ml (Figs. 2E, F, and G). Electron microscopic
examination of the pelleted particles of both D2(HIVluc) and
D2VSV(HIVluc) revealed spherical particles with homogenous
core structure (Figs. 2D and H). Taken together, these findings
suggest that the E protein of DENV2 and HIV-1 core proteins
are incorporated into the particles of both D2(HIVluc) and
D2VSV(HIVluc) with very similar sedimentation properties
and morphological features.
Since the buoyant density of D2(HIVluc) and D2VSV
(HIVluc) was very similar to that of the HIV-1 gag particle
(1.15 g/ml) (Freed and Martin, 2001; Spearman and Ratner,
1996), we carried out an immunoprecipitation experiment, in
which pellet D2(HIVluc) derived from culture supernatants of
293T cells co-transfected with pCB-D2 and pNL4-3.Luc.R-E−,
as well as mixture of pellets each from those transfected with
pCB-D2 alone or pNL4-3.Luc.R-E− alone, were immunopre-
cipitated with anti-E MAb and subjected to Western blot
analysis. As shown in Fig. 3, HIV-1 core proteins were readily
detected in the pellet D2(HIVluc) but not in the mixed pellets of
pCB-D2 and pNL4-3.Luc.R-E− transfectants, demonstrating
that dengue E proteins and HIV-1 gag are present in the same
particle.
The pseudotype reporter viruses are infectious
To investigate whether the pseudotype reporter viruses were
infectious, equal amounts of D2(HIVluc), D2VSV(HIVluc) and
VSV(HIVluc) reporter viruses, standardized by the levels ofp24 (Hsu et al., 2003; Nie et al., 2004), were inoculated into a
panel of cell lines that have been reported to support dengue
virus replication, including 293T, HeLa, Huh7, HepG2, BHK-
21, Vero and K562 (Diamond et al., 2000; Kurane et al., 1990).
While VSV(HIVluc), which contained the E protein derived
from a virus with broad tropism, infected all the cells tested with
the luciferase activity of cell lysates ranging from 105 to
107 RLU/s, D2(HIVluc) and D2VS(HIVluc) infected Huh7 and
HepG2 cells with the luciferase activity ranging from 102 to
103 RLU/s (data not shown). We therefore used Huh7 or HepG2
Fig. 3. Immunoprecipitation of the pseudotype reporter virus, D2(HIVluc).
Pellet D2(HIVluc) derived from culture supernatants of 293T cells co-
transfected with pCB-D2 and pNL4-3.Luc.R-E−, as well as mixture of pellets
each from those transfected with pCB-D2 alone or pNL4-3.Luc.R-E− alone,
were immunoprecipitated with anti-E MAb 4G2 (Henchal et al., 1982) and
subjected to Western blot analysis by using serum from dengue patient (anti-
DV) or HIV-1 patient (anti-HIV). Arrowheads indicate the structure proteins of
dengue virus and HIV-1, and asters indicate the mouse heavy chain. The size of
molecular weight markers is shown in kilodaltons.
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(HIVluc) and D2VSV(HIVluc), we titrated down the amounts
of p24 in the inoculum and carried out infectivity assay in Huh7
cells. As shown in Fig. 4, a dose-dependent relationship was
observed for both D2(HIVluc) and D2VSV(HIVluc). There was
no drastic difference in the level of luciferase activity between
these two reporter viruses, indicating that replacement of the
TM domain of DENV2 with the TM and CY domains of VSV-
G dose not result in increase in infectivity of the pseudotype
reporter virus. Similar findings were also observed in HepG2
cells (data not shown). We thus focused on the pseudotype
reporter viruses that contained the authentic dengue PrM/EFig. 4. Relationship between inoculum and luciferase activity of the pseudotype
reporter viruses. Increasing amounts of D2(HIVluc) (black bars) and D2VSV
(HIVluc) (hatched bars), as standardized by HIV-1 p24, were inoculated into
Huh7 cells and the luciferase activity of cell lysates was determined 48 h later.
Mock refers to no virus inoculated. The experiments have been repeated more
than three times. Data are means of triplicate wells of one representative
experiment and the error bars represent the standard errors of the means.proteins, including D2(HIVluc) and reporter viruses of other
serotypes (see below), in our further experiments.
pH-dependent entry of pseudotype reporter virus
Like other flaviviruses, dengue virus is believed to enter cells
through receptor-mediated endocytosis, a process sensitive to
low pH environment in the endosome (Guirakhoo et al., 1993;
Lindenbach and Rice, 2001; Mellman et al., 1986; Mukho-
padhyay et al., 2005; Randolph and Stollar, 1990). To
investigate entry of the pseudotype reporter virus, Huh7 cells
were treated with increasing concentrations of two lysosomo-
tropic agents, Bafilomycin A and ammonium chloride, and
infected with D2(HIVluc) and VSV(HIVluc), which has been
shown to enter cells through a pH-dependent route (Hsu et al.,
2003; Nie et al., 2004; Simmons et al., 2004; Wool-Lewis and
Bates, 1998). As shown in Fig. 5A, near 100% reduction of the
luciferase activities was observed in both D2(HIVluc)-infected
and VSV(HIVluc)-infected cells as the concentration of
Bafilomycin A increased to 100 nM. Similarly, the luciferase
activities of D2(HIVluc)-infected and VSV(HIVluc)-infected
cells reduced more than two logs as ammonium chloride
increased to 200 mM (Fig. 5B). Of note was that no significant
cytotoxicity was found for either Bafilomycin A or ammonium
chloride-treated cells at these concentrations, as was reported
previously (Hsu et al., 2003). Taken together, these findings
suggest that the pseudotype reporter virus, D2(HIVluc), enters
cells through a pH-dependent mechanism.Fig. 5. pH dependency of infectivity of the pseudotype reporter virus, D2
(HIVluc). Huh7 cells were treated with increasing concentration of Bafilomycin
A (A) or NH4Cl (B) 30 min prior to infection with VSV(HIVluc) (open bars), D2
(HIVluc) (black bars) or mock (hatched bars), and the luciferase activity of cell
lysates was determined 48 h later. The experiments have been repeated more
than three times. Data are means of triplicate wells of one representative
experiment and the error bars represent the standard errors of the means.
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other serotypes
To further generate pseudotype reporter viruses of three other
dengue serotypes using a similar strategy, we constructed the
PrM/E-expressing vectors (pCB-D1, pCB-D3 and pCB-D4) for
DENV1, DENV3 and DENV4 (Fig. 6A). Western blot analysis
of cell lysates derived form 293T cells co-transfected with
pNL4-3.Luc.R-E− and pCB-D1, pCB-D3 or pCB-D4 revealedFig. 6. Generation of pseudotype reporter viruses, D1(HIVluc), D3(HIVluc) and
D4(HIVluc). (A) Schematic drawing of constructs expressing PrM/E proteins of
DENV1, DENV3 and DENV4, which were generated as described in Fig. 1.
(B, C) Plasmid pCB-D1, pCB-D3 or pCB-D4 was co-transfected with pNL4-3.
Luc.R-E− to 293T cells (Connor et al., 1995). 60 h later, cell lysates (B) and
pellet lysates (C) derived from sucrose cushion ultracentrifugation were
subjected to Western blot analysis. The data are presented as described for
Fig. 1. (D) Equal amounts of the four pseudotype reporter viruses and VSV
(HIVluc), as standardized by HIV-1 p24, were inoculated into HepG2 cells and
the luciferase activity of cell lysates was determined 48 h later. Mock refers to no
virus inoculated, and pNL4-3.Luc.R-E− refers to inoculation of pellets derived
from pNL4-3.Luc.R-E− transfectant. The experiments have been repeated more
than three times. Data are means of duplicate wells of one representative
experiment and the error bars represent the standard errors of the means.readily detectable PrM and E proteins, indicating that expres-
sion of the PrM/E proteins of these three dengue serotypes was
intact (Fig. 6B). Moreover, Western blot analysis of pellets
derived from supernatants revealed that HIV-1 core proteins and
PrM/E proteins of DENV1, DENV3 and DENV4 were present
in the pseudotype reporter viruses, D1(HIVluc), D3(HIVluc)
and D4(HIVluc), respectively (Fig. 6C). We then examined the
infectivity of these three pseudotype reporter viruses in HepG2
cells. As shown in Fig. 6D, luciferase activities derived from D1
(HIVluc)-, D3(HIVluc)-, or D4(HIVluc)-infected cells ranged
from 1.6 to 2.2×102 RLU/s, similar to those from D2(HIVluc)-
infected cells.
Pseudotype reporter viruses containing mutant E proteins
To further demonstrate that entry of the pseudotype reporter
virus is mediated through the fusion loop of E protein, mutant
pCB-D1 constructs containing amino acid substitutions of the
leucine at position 107, which was a critical residue of the fusion
loop of E protein (Modis et al., 2004), with a hydrophobic
residue (alanine), a negatively charged residue (aspartic acid), or
a positively charged residue (lysine) were generated and co-
transfected with pNL4-3.Luc.R-E− to generate mutant pseudo-
type reporter viruses (Fig. 7A). As shown in Fig. 7B, PrM/E
proteins were readily detectable in cell lysates derived from
transfectants of D1-107LA(HIVluc), D1-107LD(HIVluc) and
D1-107LK(HIVluc), indicating that the mutations introduced
did not affect the expression of PrM/E proteins. Compared with
those in the wild type, detectable but less amounts of PrM/E
proteins were found in pellets of these mutants, suggesting that
incorporation of dengue viral proteins into particles was
somewhat affected (Fig. 7C). Of note, the luciferase activity in
D1-107LA(HIVluc)-infected cells was similar to that in wild
type-infected cells, suggesting that the defect in incorporation of
dengue viral proteins into D1-107LA(HIVluc) did not affect its
infectivity (Fig. 7D). In contrast, a mild decrease and a drastic
decrease in luciferase activity were found in the D1-107LD
(HIVluc)-infected and D1-107LK(HIVluc)-infected cells,
respectively. Since mutants D1-107LD(HIVluc) and D1-
107LK(HIVluc) had the incorporation defect similar to that of
D1-107LA(HIVluc), which did not affect infectivity, the
decrease in infectivity of these two mutants suggest that amino
acid substitutions of the leucine residue 107 with a charged
residue, especially a positively charged residue, affect the entry
of the pseudotype reporter viruses (Fig. 7D).
Discussion
E protein is the major determinant of cellular tropism, viral
entry and neutralization sensitivity of enveloped viruses. With
the advancement of molecular technologies, several pseudotype
reporter viral systems have been developed for different
enveloped viruses and made the investigation of phenotypic
properties of E proteins more conveniently and efficiently
(Bartosch et al., 2003; Buonocore et al., 2002; Chan et al., 2001;
Cronin et al., 2005; Deng et al., 1996, 1997; Fukushi et al., 2005;
Giroglou et al., 2004; Hanika et al., 2005; Hsu et al., 2003; Ma et
Fig. 7. Pseudotype reporter viruses containing mutant E proteins. (A) Schematic
drawing of pCB-D1 constructs expressing mutant E proteins. Plasmid pCB-D1,
pCB-D1-107LA, pCB-D1-107LD or pCB-D1-107LK was co-transfected with
pNL4-3.Luc.R-E− to 293T cells (Connor et al., 1995). 60 h later, cell lysates (B)
and pellet lysates (C) derived from sucrose cushion ultracentrifugation were
subjected toWestern blot analysis. The data are presented as described for Fig. 1.
(D) Equal amounts of the wild type and mutant pseudotype reporter viruses, as
standardized by HIV-1 p24, were inoculated into HepG2 cells and the luciferase
activity of cell lysates was determined 48 h later. Mock refers to no virus
inoculated. The experiments have been repeated more than three times. Data are
means of duplicate wells of one representative experiment and the error bars
represent the standard errors of the means.
381H.-P. Hu et al. / Virology 368 (2007) 376–387al., 1999; Matsuura et al., 2001; Moore et al., 2004; Nie et al.,
2004; Simmons et al., 2004; Wool-Lewis and Bates, 1998). In
this study, we have successfully established a retrovirus-based
pseudotype reporter virus for four serotypes of dengue viruses.
Compared with the traditional infectivity assay for dengue virus,
this is a simple, sensitive and convenient tool to study the
function of PrM/E proteins in the context of viral particles. To
our knowledge, this is the first reporter viral system reported for
dengue virus thus far.Sucrose gradient analysis of the pseudotype reporter viruses
revealed co-sedimentation of the majority of dengue E protein
and HIV-1 core proteins, suggesting that dengue viral proteins
were incorporated into the particles formed by HIV-1 core. The
buoyant density of the pseudotype reporter virus, D2(HIVluc),
was 1.14 g/cm3, which was similar to that of a HIV-1 gag particle
(1.15 g/cm3) and subviral particles of flaviviruses (1.14 g/cm3)
but lower than that of a flaviviral particle (range: 1.19 to 1.23 g/
cm3) (Freed and Martin, 2001; Lindenbach and Rice, 2001;
Schalich et al., 1996; Spearman and Ratner, 1996). Therefore, an
immunoprecipitation experiment was carried out to further
demonstrate that dengue E proteins and HIV-1 gag are indeed
present in the same particle (Fig. 3). Of note, since subviral
particles of several flaviviruses including dengue virus can be
produced by co-expression of PrM and E proteins (Allison et al.,
1995; Konishi et al., 1992; Mason et al., 1991; Schalich et al.,
1996), these subviral particles may compete with the assembly
of our pseudotype reporter viruses and thus account for the
relatively low infectivity observed. Re-examination of the
electron micrographs revealed some small particles of 30 to
50 nm in diameter, which were smaller than and distinguishable
from the dense-core particles of D2(HIVluc) (see Supplemen-
tary Fig. 1). The size of D2(HIVluc) was approximately 70 to
80 nm in diameter (Fig. 2D), which was slightly larger than that
of a mature flaviviral particle (60 nm) and smaller than that of a
HIV-1 gag particle (90 to 100 nm) (Lindenbach and Rice, 2001;
Spearman and Ratner, 1996). This suggests that certain change
in the arrangement of E proteins might have occurred to
accommodate its incorporation into the slightly larger pseudo-
type reporter particle. However, our observations that the entry
of pseudotype reporter virus is mediated through a pH-
dependent route (Fig. 5) and affected by the fusion loop
mutations (Fig. 7) suggest that the E protein on the pseudotype
reporter virus functions similarly to that on the dengue virion.
Because virion assembly and release of dengue virus and
HIV-1 occurred at different locations, we sought to generate
another pseudotype reporter virus, D2VSV(HIVluc), which
contained the membrane targeting domain of VSV-G (Rose and
Whitt, 2001), to enhance particle formation at the cell surface. A
series of analyses revealed that D2(HIVluc) and D2VSV
(HIVluc) had similar biochemical and morphological properties
except that the amount of PrM protein relative to that of E
protein in the cell and pellet lysates of D2VSV(HIVluc) was
less than that of D2(HIVluc) (Figs. 1B and C). Since the TM
domain of E protein of tick-borne encephalitis virus, another
flavivirus, has been shown to be involved in the interaction with
PrM protein (Allison et al., 1999), less amount of PrM protein
could be due to the relatively weaker interaction between E and
PrM proteins in D2VSV(HIVluc), which lacked the TM domain
of DENV2. However, this did not lead to significant difference
in infectivity (Fig. 4). Moreover, our findings of no increase in
the infectivity of D2VSV(HIVluc), compared with that of D2
(HIVluc), would suggest that replacement of the TM domain of
DENV2 with the TM and CY domains of VSV-G does not
result in increased particle formation at the cell surface and thus
increased infectivity. Immunofluorescence study of intracellular
distribution of E protein revealed that there was no increase in
Fig. 8. Binding of the pseudotype reporter virus, D2(HIVluc) to target cells.
HepG2 (A), Vero cells (B) and BHK-21 cells (C) were inoculated with equal
amounts of D2(HIVluc) and pellets derived from pNL4-3.Luc.R-E− transfectant
at 4 °C for 1.5 h. After washing, cell lysates were subjected to Western blot
analysis. The data are presented as described for Fig. 1.
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(HIVluc), supporting this interpretation (data not shown). In
addition, enzymatic digestion of E proteins in lysates derived
from D2(HIVluc) and D2VSV(HIVluc)-producing cells
showed predominantly endoglycosidase H-sensitive pattern,
suggesting strong ER retention of E proteins for both D2
(HIVluc) and D2VSV(HIVluc) (data not shown). Of note, the
stem region (amino acid residues 396 to 452) of DENV2 E
protein has been recently reported to contain an ER retention
signal (Purdy and Chang, 2005). Thus, our findings that the E
protein of D2VSV(HIVluc) retained mainly in ER suggest that
the ER retention signal of DENV2 stem region has a stronger
effect than the membrane-targeting signal of VSV-G (Rose and
Whitt, 2001).
Enveloped viruses enter cells through two main pathways,
direct fusion at the plasma membrane and receptor-mediated
endocytosis (Lindenbach and Rice, 2001). Our findings that the
luciferase activities in D2(HIVluc)-infected cells were com-
pletely inhibited by the lysosomotropic agents, Bafilomycin A
and ammonium chloride, suggest that the pseudotype reporter
virus enters cells through a pH-dependent pathway, a route that
was utilized by dengue virus (Guirakhoo et al., 1993;
Lindenbach and Rice, 2001; Mukhopadhyay et al., 2005;
Randolph and Stollar, 1990). Similarly, the pseudotype reporter
virus of HCV, another flavivirus, also utilized the pH-dependent
pathway to enter cells (Bartosch et al., 2003; Hsu et al., 2003).
Although a variety of cell lines could be productively infected
by dengue virus (Diamond et al., 2000; Kurane et al., 1990),
only two of them (Huh7 and HepG2 cells, both human cells)
were shown to be infected by the dengue pseudotype reporter
virus, as revealed by the luciferase activity. To examine whether
the pseudotype reporter virus can bind HepG2 cells as well as
two common target cells of dengue virus, Vero and BHK-21
cells, equal amounts of D2(HIVluc) and pellets derived from
pNL4-3.Luc.R-E− transfectant were inoculated to these cells at
4 °C for 1.5 h, and cell lysates containing the bound particles
were subjected to Western blot analysis. As shown in Fig. 8,
similar amounts of dengue E protein and HIV-1 core proteins
were detected in lysates of HepG2, Vero and BHK-21 cells
inoculated with D2(HIVluc) but not in those inoculated with
pellets of pNL4-3.Luc.R-E− transfectant, indicating that D2
(HIVluc) can bind Vero and BHK-21 cells. Similarly, binding to
Vero and BHK-21 cells was also observed for D1(HIVluc), D3
(HIVluc) and D4(HIVluc) (data not shown). Thus, the lack of
luciferase activity in these two cells could be due to the
relatively poor expression of the HIV-based reporter gene in
many non-human cells (Besnier et al., 2002; Freed and Martin,
2001). In agreement with this interpretation, VSV(HIVluc),
which contained a broad-tropic envelope glycoprotein (VSV-
G), had more than two-logs difference (105 to 107 RLU/s) in the
luciferase activity in various target cells, with the highest
activities in human cell lines, including 293T, Huh7 and HepG2
cells (data not shown). Similarly, another HIV-based β-gal
reporter virus pseudotyped with VSV-G had three-log differ-
ence in the reporter signal (104 to 107 focus-forming units/ml)
in different target cells with the highest signals in human cells
(Simmons et al., 2004).We have generated pseudotype reporter viruses of other three
serotypes and demonstrated that they had similar biochemical
properties and infectivity (Fig. 6). Of note, the amount of PrM
protein relative to that of the E protein in the cell and pellet
lysates of D4(HIVluc) was less than that in other pseudotype
reporter viruses. This could be due to the serum used, which was
from a confirmed DENV2 patient and recognized the PrM
protein of DENV4 less well than that of other serotypes (see
Supplementary Fig. 2). During the maturation of flaviviral
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trans-Golgi resident protein, furin or furin-like protease (Linden-
bach and Rice, 2001; Stadler et al., 1997). Of note, the cleavage
has been shown to be ineffective for dengue virus by several
independent studies (Anderson et al., 1997; He et al., 1995;
Keelapang et al., 2004; Murray et al., 1993; Randolph et al.,
1990; Wang et al., 1999b). We have used mixed sera from dengue
patients that contained strong anti-PrM activity to examine the
PrM cleavage in our pseudotype reporter viruses, but no
discernable M protein was found probably due to ineffective
PrM cleavage (data not shown). However, the pH-dependent
entry of our pseudotype reporter viruses would suggest
incorporation of cleaved M protein, though probably at low
level. This may account for the relatively low infectivity observed
in this study. Further experiment of treating the pseudotype
reporter particles with furin based on the protocol described
previously may improve their infectivity (Stadler et al., 1997).
We have also generated pseudotype reporter viruses contain-
ing different amino acid substitutions at a critical residue,
leucine at position 107, of the fusion loop of E protein. Based on
the prediction modeled on crystal structure of E protein and the
binding of mutant E proteins to MAbs, mutations introduced to
leucine 107 were unlikely to disrupt the overall conformation of
E protein (Crill and Chang, 2004; Modis et al., 2004). Our
findings that mutants 107LA, 107LD and 107LK affect the
incorporation of dengue viral proteins into particles were
unexpected (Fig. 7). However, this defect in incorporation does
not affect the infectivity of D1-107LA(HIVluc). Since leucine
107 is highly conserved among flaviviruses and mutations
introduced to leucine 107 have been shown to impair the fusion
activity of E protein in tick-borne encephalitis virus and West
Nile virus (Allison et al., 2001; Zhang et al., 2006), the drastic
impairment in infectivity of D1-107LK(HIVluc), which had
incorporation defect similar to that of D1-107LA(HIVluc), was
most likely at the fusion step of entry.
With the current technique of virus isolation and sequencing,
more and more dengue viruses from outbreaks in different
countries of the world have been isolated, and increasing
numbers of E or full-genome sequences are available now
(Carrington et al., 2005; Guzman and Kouri, 2002; Zhang et al.,
2005). However, an efficient system to characterize the pheno-
typic properties of different E sequences, which are important to
our understanding of the pathogenesis of dengue as well as to
the evaluation of candidate vaccines, is lacking. In this regard,
our dengue pseudotype reporter viruses have the potential to
further molecular characterization of PrM/E proteins of dengue
field isolates in the future.
Materials and methods
Construction of PrM/E expression plasmids
RNA were extracted from culture supernatants of DENV1
(Hawaii strain), DENV2 (16681 strain), or DENV3 (ID23
strain) infected C6/36 cells, and subjected to RT using random
primers as described previously (Lin et al., 2004). Full-length
PrM/E genes and the 3′ 42-nucleotide region of the C gene(corresponding to amino acid residues 101 to 114, which encode
the signal peptide) of four serotypes of dengue viruses were
amplified by using cDNA templates (for DENV1, DENV2 and
DENV3) or plasmid p2AXhoI (for DENV4, 814669 strain,
kindly provided by Dr. C. J. Lai) (Lai et al., 1991) and the
following primer pairs: d1KpnSSA (5′-CTTGGTACCGCCG-
CCGCCATGTCTGTGACCATGCTCCTC-3′) and d1E495BNotI
(5′-CTTCGAGCGGCCGCAATTACGCCTGAACCAT-
GACTCCTAG-3′) for DENV1; d2KpnSS (5′-CTTGGTACCTC-
TAGAGCCGCCGCCATGGCAGGCATGATCATTATG-3′) and
d2NotI-2402 (5′-TTTCTCGAGCGGCCGCTCAACTAAT-
TAGGCCTGCACCATGACTC-3′) for DENV2; d3KpnSSA (5′-
CTTGGTACCGCCGCCGCCATGACATCGTTCTGTCTCAT-
GATG-3′) and d3E495BNotI (5′-CTTCGAGCGGCCGCAAT-
TAAGCTTGTACCACGGCTCCC-3′) for DENV3; d4KpnSSA
(5′-CTTGGTACCGCCGCCGCCATGACGATAACATTGCTGT-
GCTTG-3′) and d4E495BNotI (5′-CTTCGAGCGGCCGCT-
CAACTAATTATGCTTGAACTGTGAAGCCC-3′) for DENV4.
To generate PrM/E expression plasmids (pCB-D1, pCB-D2, pCB-
D3 and pCB-D4), PCR products were digested with KpnI and
NotI, and cloned into respective sites of a pCDNA3-based vector,
pCBD2-2J-2-9-1 (kindly provided byDr. G. J. J. Chang) (Chang et
al., 2003). To generate plasmid pCB-D2VSV, primers VSV457-
AXcmI (5′-GCCGTTCACCAAGTGTTTGGTGGCAG-
TAGTTG GAAAAGCTCTATTG-3′) and VSV512BNotI (5′-
TTTTCTTTTGCGGCCGCTCAA ACTTACT TTCCAAGTCG-
GTTCATC-3′) were used to amplify the transmembrane (TM) and
cytoplasmic (CY) domains of the glycoprotein of vesticular
stomatitis virus (VSV) from plasmid pVSV-G. The PCR product
was digested with XcmI and NotI, and cloned into the respective
sites of pCB-D2.
Generation of pseudotype reporter viruses
Human embryonic kidney cells, 293Tcells, weremaintained in
Dulbecco's modified Eagle medium (DMEM) (JRH Biosciences,
Lenexa, KS) containing 10% fetal bovine serum (FBS), 1%
antibiotics (penicillin/streptomycin) and 1% HEPES (Gibco
Invitrogen, Carlsbad, CA), and seeded in 10-cm2 dishes 1 day
prior to transfection. 6 μg of each of the PrM/E expression
plasmids (pCB-D1, pCB-D2, pCB-D2VSV, pCB-D3, pCB-D4)
or of the plasmid pVSV-G were co-transfected with 6 μg of a
previously described lentivirus-based luciferase reporter con-
struct, pNL4-3.Luc.R-E− (Connor et al., 1995), using the calcium
phosphate method (Chen and Okayama, 1987). Briefly, plasmids
were mixed with 30 μl of 0.25 M CaCl2, 300 μl of 2× BBS,
incubated at room temperature for 10 to 20 min, and added
dropwise to the cells, which were incubated at 35 °C for 15 h to
24 h and replaced with 15 ml fresh medium. After incubation at
37 °C for 48 h, the cells were washed with 1× PBS once, treated
with lysis buffer (1% NP-40, 50 mMTris, pH 8.0, 150 mMNaCl,
2 mM EDTA, 1 mM Na3VO4, and proteinase inhibitor, Roche,
Germany) at 4 °C, followed by centrifugation at 14,000 rpm (851
rotor, Thermo Electron Corporation, Waltham, MA) at 4 °C for
30min to obtain cell lysates forWestern blot analysis (see below).
Culture supernatants containing pseudotype reporter virus were
clarified by centrifugation at 2500 rpm (A-4-62 rotor, Eppendorf,
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membranes, layered over a 20% sucrose buffer, and subjected to
ultracentrifugation at 19,000 rpm (SW28 rotor, Beckman, Full-
erton, CA) at 4 °C for 5 h. The pellets were resuspended in 1 ml
medium, filtered through 0.22-μm filter, and stored at −80 °C
until use (Wang et al., 1999a). The amount of p24 in the
pseudotype reporter virus was assessed by an HIV-1 p24 antigen
ELISA kit (Murex HIVAntigen Mab, Abbort, IL).
Cells and infectivity of pseudotype viruses
Huh7 cells and HeLa cells were maintained in DMEM
containing 10% FBS and 1% antibiotics (Gibco Invitrogen,
Carlsbad, CA). BHK-21 cells and K562 cells were maintained in
RPMI-1640 (JRH Buiscuebces, Lenexa, KS) containing 5% FBS
and 1% antibiotics. HepG2 cells and Vero cells were maintained
in minimal essential medium containing 10% FBS and 1%
antibiotics. For infectivity assay, cells (1×105 cells) were seeded
in 24-well plate 1 day earlier, and known amounts (18 to 36 ng of
p24) of pseudotype virus were added and incubated at 37 °C for
18 h, followed by replacement with fresh medium. About 48 h
later, medium was removed and cells were washed with 1× PBS
and lysed with 80 μl lysis buffer per well (Promega, Madison,
WI). 20 μl of lysates were tested for luciferase activity using a
microplate luminometer (Berthold Detection Systems, Oak
Ridge, TN).
Inhibition of entry
Huh7 cells were pre-incubated with or without different
concentration ofNH4Cl or BafilomycinA (Sigma, St. Louis,MO)
at 37 °C for 30 min, infected with known amounts of pseudotype
virus (18 ng of p24), and incubated in the presences or absence of
inhibitors at 37 °C for 18 h. Fresh medium was replaced and cells
were lysed 48 h later to determine luciferase activity as described
above.
Cytotoxicity assay
Huh7 cells were incubated with or without different
concentration of inhibitors at 37 °C. After 48 h to 72 h, medium
was collected for a cytotoxicity assay (CytoTox 96, Promega,
Madison, WI). Briefly, each sample was added with reconstitute
substrate mix (50 μl) and incubated at room temperature for
30min. After adding stop solution, the background absorbance (at
490 nm), which was the LDH spontaneously released from cells
without inhibitors, was subtracted from the sample absorbance (at
490 nm) to determine the experimental LDH release. The
percentage of cytotoxicity was the ratio of the experimental
LDH release to the maximum LDH release, which was the LDH
released after the freeze–thaw cycle of the cells.
Western blot analysis of cell lysates and particles of pseudotype
viruses
An aliquot (200 μl) of the pseudotype reporter virus
concentrated by 20% sucrose cushion as described above wassubjected to centrifugation at 14,000 rpm (F-45-30-11 rotor,
Eppendorf, Westbury, NY) at 4 °C for 1 h to obtain pellets,
which was resuspended in 15 μl TNE buffer (50 mM Tris–HCl,
pH 8.0, 1 M NaCl, 10 mM EDTA) for Western blot analysis and
electron microscopy (see below). Another aliquot (800 μl) was
subjected to sucrose gradient (15% to 80% (wt./vol.) in TNE
buffer) ultracentrifugation at 25,000 rpm (SW41 rotor, Beck-
man, Fullerton, CA) at 4 °C for 16 h. Each 1 ml fraction was
collected from top of the gradient and subjected to ultracen-
trifugation at 22,000 rpm (SW55 rotor, Beckman, Fullerton,
CA) at 4 °C for 1.5 h. Cell lysates, pellets and pellet of each
fraction were subjected to 12% SDS–PAGE and Western blot
analysis with serum (1:5000) from a dengue patient (Wang et
al., 2006) or an HIV-1 patient (Lee et al., 2000) (kindly provided
by Dr. C. N. Lee). The density of each fraction was determined
by a refractometer (ATAGO, Tokyo, Japan) as described
previously (Hsieh et al., 2005).
Electron microscopy
An aliquot of the pelleted particles was added to a 300-mesh
formvar/carbon film, stained with saturated uranyl acetate
(Electron Microscopy Sciences, Washington, PA), and exam-
ined by electron microscope.
Immunoprecipitation
15 μl of pellets derived from culture supernatants of 293T
cells co-transfected with pCB-D2 and pNL4-3.Luc.R-E− as
described above, as well as mixture of equal amounts of pellets
(15 μl) from those transfected with pCB-D2 alone and pNL4-3.
Luc.R-E− alone, were incubated with 250 μl protein A-
Sepharose beads (Amersham Pharmacia Biotech., Piscataway,
NJ), and 10 μl of a mouse anti-E monoclonal antibody (MAb)
4G2 (1:100) (American Type Culture Collection, Rockville,
MD) (Henchal et al., 1982) at 4 °C overnight. After washing four
times with 1% NP-40, the immunoprecipitates were mixed with
2× sample buffer (500 mMTris, pH 6.8, 4% SDS, 20% glycerol,
0.4% bromophenol blue), eluted by heating at 95 °C for 2 min,
and subjected to Western blot analysis.
Generation of E mutants of pCB-D1
Site-directed mutagenesis was performed by using pCB-D1
template and the two-step PCR mutagenesis as described
previously to mutate the leucine at position 107 to alanine,
aspartic acid or lysine (Liu et al., 2003). In the first PCR, a
fragment of 317 bp (fragment A) was amplified by primer pair,
d1E2XcmIA (5′-CATGGCCATGCGATGCGTGGGAATAG-
3′) and d1EL107KB1 (5′-ACCTTTTCCGAATTTCCCACAG-
CCATT-3′) for pCB-D1-107LK or by primer pair, d1E2XcmIA
and d1EL107A/DB1 (5′-ACCTTTTCCGAAAG/TCCCCA-
CAGCCATT-3′) for pCB-D1-107LA and pCB-D1-107LD.
Another fragment of 127 bp (fragment B) was amplified by
primer pair, d1EL107KA2 (5′-AATGGCTGTGGGAAATTCG-
GAAAAGGT-3′) and d1E150DraIIIB (5′-ATTTCCCACCT
GGTGCTGGTC-3′) for pCB-D1-107LK or by primer pair,
385H.-P. Hu et al. / Virology 368 (2007) 376–387d1EL107A/DA2 (5′-AATGGCTGTGGGGC/ATTTCGGAA-
AAGGT-3′) and d1E150DraIIIB for pCB-D1-107LA and
pCB-D1-107LD. In the second PCR, a product of 444 bp was
obtained by usingmixture of fragments A andB as templates and
outer primers (d1E2XcmIA and d1E150DraIIIB), digested with
XcmI and DraIII, and cloned into respective sites of a pCB-D1.
All mutants were confirmed by sequencing in the entire 444-bp
region to exclude the second site mutation.
Binding of pseudotype reporter virus to target cells
Huh7, HepG2, BHK-21 or Vero cells (1×105) were pretreated
with cold medium at 4 °C for 30 min and incubated with equal
amounts (based on p24) of pseudotype reporter viruses, D1
(HIVluc), D2(HIVluc), D3(HIVluc), D4(HIVluc), and pellets
derived from pNL4-3.Luc.R-E− transfectants at 4 °C for 1.5 h.
After washing with cold medium twice, cell lysates containing
bound particles were subjected to Western blot analysis.
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